North America Competent Cells Market By Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

North America Competent Cells Market By Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

ID: 3483 | Pages: 128 | October 2018 | Region: North America


Overview of the Market:
The North America Competent Cells Market is worth USD 0.63 billion in 2018 and estimated to grow at a CAGR of 10.51%, to reach USD 1.04 billion by 2023. The North America Competent Cells market is developing at an exceptionally quick pace.

In biology, genetics, and molecular biology, competence is the capacity of a cell to take up extracellular (unprotected) DNA from its environment in the process called transformation. E. coli cells are more likely to incorporate external DNA if their cell walls are changed so that DNA can badge through more easily. Cells are made competent by a method that uses calcium chloride and high temperature shock.

The development of the ccompetent cells segment can be attributed to the increasing intensity of study (due to technical advancement) and availability of government support, along with the growing market demand for molecular cloned products. However, growing market union creating strong entry barriers are restricting the growth of this market.

The North America market for Competent Cells is segmented on the basis of type, application, end user and region. Based on type, the market is segmented into Chemically, Electrocompetent. Based on application, the market is segmented into Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, and Mutagenesis. The chemically competent cells segment is expected to dominate the market in 2016. Cloning is estimated to command the major share of this market in 2017. Increasing study on cloning, driven by government funding is among the major reasons driving market growth in this segment. Based on end user, the market is segmented into Pharmaceutical Companies, Academia. Cloning is estimated to command the major share of this market in 2017. Increasing study on cloning, driven by government funding is among the major reasons driving market growth in this segment. In 2016, the academic research institutes segment is likely to have for the largest share of the market.

Geographical Analysis: 
The North America market has been geographically segmented into segmented into US, Canada and Mexico. North America has the highest no. share in the Metabolomics market.USA has the highest demand followed by Canada and Mexico. The North America region is largely driven by environmental concerns.

Key Players in this Market
BioDynamics Laboratory, Inc. (Japan), GCC Biotech (India), SMOBIO Technology (Taiwan),  Thermo Fisher Scientific, Inc. (U.S), QIAGEN N.V. (Germany), OriGene Technologies (U.S.), Merck KGaA (Germany), Promega Corporation (U.S.),  Bioline (U.K.), Zymo Research (U.S.),are the leaders in the North America Competent Cells market.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Chemically               

                                5.1.2 Electrocompetent

                                5.1.3  Y-o-Y Growth Analysis, By Type    

                                5.1.4  Market Attractiveness Analysis, By Type  

                                5.1.5  Market Share Analysis, ByType     

                5.2 Application                 

                                5.2.1 Cloning     

                                                5.2.1.1  Subcloning & Routine Cloning

                                                5.2.1.2 Phage Display Library Construction

                                                5.2.1.3 Toxic/Unstable Dna Cloning

                                                5.2.1.4 High-Throughput Cloning

                                5.2.2 Protein Expression              

                                5.2.3 Other Applications               

                                                5.2.3.1 Mutagenesis

                                                5.2.3.2 Large Plasmid Transformation

                                                5.2.3.4 Single-Stranded Dna Production

                                                5.2.3.5 Lentiviral Vector Production

                                5.2.7 Y-o-Y Growth Analysis, By Application         

                                5.2.8  Market Attractiveness Analysis, By Application      

                                5.2.9  Market Share Analysis, By Application       

                5.3 End User                      

                                5.3.1 Pharmaceutical Companies              

                                5.3.2 Academia

                                5.3.3 Y-o-Y Growth Analysis, By EndUser              

                                5.3.4  Market Attractiveness Analysis, By EndUser           

                                5.3.5  Market Share Analysis, By EndUser             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By Application

                                                6.1.3.4 By EndUser

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By Application

                                                6.1.4.4 By EndUser

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By Application

                                                6.1.5.4 By EndUser

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 BioDynamics Laboratory, Inc. (Japan)                              

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GCC Biotech (India)                 

                8.3 SMOBIO Technology (Taiwan)                            

                8.4 Thermo Fisher Scientific, Inc. (U.S)                   

                8.5 QIAGEN N.V. (Germany)                      

                8.6 OriGene Technologies (U.S.)                              

                8.7 Merck KGaA (Germany)                       

                8.8 Promega Corporation (U.S.)                

                8.9 Bioline (U.K.)                             

                8.10 Zymo Research (U.S.)                          

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. North America Competent cells Market By Type, From 2018-2023 ( USD Million )
  2. North America Chemically Market By Region, From 2018-2023 ( USD Million )
  3. North America Electro Competent Market By Region, From 2018-2023 ( USD Million )
  4. North America Competent cells Market By Application, From 2018-2023 ( USD Million )
  5. North America SubCloning Market By Region, From 2018-2023 ( USD Million )
  6. North America Phage Display Library Production Market By Region, From 2018-2023 ( USD Million )
  7. North America Unstable DNA Cloning Market By Region, From 2018-2023 ( USD Million )
  8. North America High-Throughput Cloning Market By Region, From 2018-2023 ( USD Million )
  9. North America  Mutagenesis Market By Region, From 2018-2023 ( USD Million )
  10. North America Competent cells Market By End User, From 2018-2023 ( USD Million )
  11. North America Pharmaceutical Companies Market By Region, From 2018-2023 ( USD Million )
  12. North America Academia Market By Region, From 2018-2023 ( USD Million )
  13. United States Competent cells Market By Type, From 2018-2023 ( USD Million )
  14. United States Competent cells Market By Application, From 2018-2023 ( USD Million )
  15. United States Competent cells Market By End User, From 2018-2023 ( USD Million )
  16. Canada Competent cells Market By Type, From 2018-2023 ( USD Million )
  17. Canada Competent cells Market By Application, From 2018-2023 ( USD Million )
  18. Canada Competent cells Market By End User, From 2018-2023 ( USD Million )
Latin America Non-Invasive Cancer Diagnostics Market By Technology (Molecular Diagnostics, Clinical Chemistry, Clinical Instruments, Immunochemistry), By Therapeutics (Solid Tumours, Breast Cancer, Blood Cancer, Lun...
Asia Pacific Non-Invasive Cancer Diagnostics Market By Technology (Molecular Diagnostics, Clinical Chemistry, Clinical Instruments, Immunochemistry), By Therapeutics (Solid Tumours, Breast Cancer, Blood Cancer, Lung...
Europe Non-Invasive Cancer Diagnostics Market By Technology (Molecular Diagnostics, Clinical Chemistry, Clinical Instruments, Immunochemistry), By Therapeutics (Solid Tumours, Breast Cancer, Blood Cancer, Lung Cance...
North America Non-Invasive Cancer Diagnostics Market By Technology (Molecular Diagnostics, Clinical Chemistry, Clinical Instruments, Immunochemistry), By Therapeutics (Solid Tumours, Breast Cancer, Blood Cancer, Lun...
Non-Invasive Cancer Diagnostics Market By Technology (Molecular Diagnostics, Clinical Chemistry, Clinical Instruments, Immunochemistry), By Therapeutics (Solid Tumours, Breast Cancer, Blood Cancer, Lung Cancer, Othe...
Middle East And Africa Microbiology Testing/Clinical Microbiology Market By Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), By Clinical Application (Respiratory Diseases, STD, UTI), By Pr...
Latin America Microbiology Testing/Clinical Microbiology Market By Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), By Clinical Application (Respiratory Diseases, STD, UTI), By Product (in...
Asia-Pacific Microbiology Testing/Clinical Microbiology Market By Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), By Clinical Application (Respiratory Diseases, STD, UTI), By Product (ins...
Europe Microbiology Testing/Clinical Microbiology Market By Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), By Clinical Application (Respiratory Diseases, STD, UTI), By Product (instrumen...
North-America Microbiology Testing/Clinical Microbiology Market By Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), By Clinical Application (Respiratory Diseases, STD, UTI), By Product (in...
Microbiology Testing/Clinical Microbiology Market By Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), By Clinical Application (Respiratory Diseases, STD, UTI), By Product (instruments, Ana...
Middle East And Africa Insect Pest Control Products Market By Type (Termites, Cockroaches, Bed Bugs, Mosquitoes, Flies, Ants), By Control Method (Chemical, Physical & Mechanical, Biological), By Application (Commerc...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2019 Market Data Forecast
All Rights Reserved.